GlassScriptPhysician profile
Samuel W Carlson
NPI 1184151524
$14,038.65
in general payments reported to CMS, 2019-2025
10 companies · $1,310 in 2025
The $1,310 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $281 · 2021: $247 · 2022: $3,907 · 2023: $7,861 · 2024: $124 · 2025: $1,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,195 · Food and Beverage: $3,600 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,195.06 |
| Food and Beverage | $3,600.24 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $8,222.62 | 2022-2023 | Djo Surgical |
| Stryker Corporation | $2,436.08 | 2019-2025 | Mako, Accolade, Triathlon |
| Zimmer Biomet Holdings, INC. | $1,909.89 | 2023 | Arcos, Persona, G7 |
| Depuy Synthes Sales INC. | $582.10 | 2019-2025 | Attune, Va-Lcp |
| Osteoremedies, LLC | $419.17 | 2022-2023 | Remedy Spacer, Remedy Spectrum Gv Spacer |
| Smith+Nephew, INC. | $136.61 | 2023 | Or3o Dual Mobility, Redapt |
| Medical Device Business Services, INC. | $124.82 | 2024-2025 | Velys |
| Kci USA, INC. | $111.11 | 2023 | Prevena |
| Linkbio Corp | $73.06 | 2023 | |
| Microport Orthopedics INC | $23.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.